Pharmamarketeer

Approach used against influenza epidemics could benefit COVID-19 drug development

COVID-19 drug development

A new study from researchers at The University of Texas at Austin has found that some antivirals are useful for more than helping sick people get better — they also can prevent thousands of deaths and hundreds of thousands of virus cases if used in the early stages of infection.

Medhc-fases-banner
Advertentie(s)